Ashvattha Therapeutics

Website

Developer of hydroxyl dendrimer therapeutics designed to meet the unmet medical needs in oncology, ophthalmology and inflammatory diseases. The company's therapeutics selectively target actively endoc...

Healthcare
Redwood City, CA, United States
Founded 2015
31 employees
Website
Valuation
$310M
Market implied
Share Price
N/A
Total Raised
$149.2M
Last Round
N/A
Investors
+37 other investors
View all 37 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Ashvattha Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required